Cargando…
Development of NMDAR Antagonists with Reduced Neurotoxic Side Effects: a Study on GK11
The NMDAR glutamate receptor subtype mediates various vital physiological neuronal functions. However, its excessive activation contributes to neuronal damage in a large variety of acute and chronic neurological disorders. NMDAR antagonists thus represent promising therapeutic tools that can counter...
Autores principales: | Vandame, Delphine, Ulmann, Lauriane, Teigell, Marisa, Prieto-Cappellini, Monica, Vignon, Jacques, Privat, Alain, Perez-Polo, Regino, Nesic, Olivera, Hirbec, Helene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834252/ https://www.ncbi.nlm.nih.gov/pubmed/24260528 http://dx.doi.org/10.1371/journal.pone.0081004 |
Ejemplares similares
-
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
por: Hemonnot, Anne-Laure, et al.
Publicado: (2019) -
Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity
por: Sabet, Mercedeh Farhat, et al.
Publicado: (2022) -
Moving beyond GK–12
por: Ufnar, J. A., et al.
Publicado: (2012) -
Okara ameliorates glucose tolerance in GK rats
por: Hosokawa, Masaya, et al.
Publicado: (2016) -
Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases
Prefrontal Global Connectivity in Depressed Patients
por: Abdallah, Chadi G., et al.
Publicado: (2018)